Solazyme, Inc. (NASDAQ:SZYM)

CAPS Rating: 4 out of 5


Player Avatar TopAustrianFool (51.59) Submitted: 12/24/2012 10:57:53 AM : Underperform Start Price: $6.64 SZYM Score: +6.19

Sooner or later these companies doing junk science will run out of lobbying money and subsidies. The only danger to shorts is govt bailing them out by pushing connected companies like GE to buy them out. Either way these companies are nothing but illusions.

Report this Post 4 Replies
Member Avatar tfaby3 (< 20) Submitted: 12/28/2012 4:43:34 PM
Recs: 0

You literally have no idea what this company does or what the profit margins are for their already-proven products. 'Junk Science' does not attract the best and brightest biotech engineers or produce attractive, market-disrupting products. The true illusions are the false claims people like you push out on investing boards. If you wish for China to beat us in the biotech game, then short away. If you're banking on American ingenuity to lead the way, then join the longs. GLTL; forget the shorting sheep.

Member Avatar TopAustrianFool (51.59) Submitted: 1/3/2013 11:25:43 AM
Recs: 0

China is not going to beat us because they print more money, waste more money/wealth and do more junk science than we do. The answer is stop subsidizing and bailing out loosers and let the free-market choose the winners.

The brightest scientists and engineers go work for anyone who is willing to pay them for their expertise. They are not interested and are not in the business of predicting what will work or not in the marketplace.

Member Avatar GUVF (51.42) Submitted: 1/9/2013 1:54:56 PM
Recs: 0

So you have a better understanding of Solazyme's science that the combined knowledge of the hundreds of engineers/scientists at Bunge, Roquette, Chevron, Dow, Unilever, United Airlines, ADM, U.S. Navy, etc...? Wow, I'm impressed.

Member Avatar TopAustrianFool (51.59) Submitted: 1/10/2013 9:43:40 PM
Recs: 0

I am in one of them.

Featured Broker Partners